This is a demo store. No orders will be fulfilled.

Chlorpromazine - 10mM in DMSO, high purity , CAS No.50-53-3, D2-like dopamine receptor antagonist

  • Cas Number:  50-53-3
  • Molecular Weight:  318.9
  • PubChem CID: 2726
In stock
Item Number
C424348
Grouped product items
SKU Size
Availability
Price Qty
C424348-1ml
1ml
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$240.90

Basic Description

Synonyms Ampliactil | chlorpromazine | Clorpromazina | Chlordelazin | HL 5746 | NSC-226514 | Cromedazine | Fraction AB | 2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine | chlorpromethazine | 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine | C
Specifications & Purity Moligand™, 10mM in DMSO
Storage Temp Store at -80°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade Moligand™
Action Type ANTAGONIST, CHANNEL BLOCKER
Mechanism of action D2-like dopamine receptor antagonist

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Benzothiazines
Subclass Phenothiazines
Intermediate Tree Nodes Not available
Direct Parent Phenothiazines
Alternative Parents Alkyldiarylamines  Diarylthioethers  Benzenoids  Aryl chlorides  1,4-thiazines  Trialkylamines  Azacyclic compounds  Organopnictogen compounds  Organochlorides  Hydrocarbon derivatives  
Molecular Framework Aromatic heteropolycyclic compounds
Substituents Phenothiazine - Alkyldiarylamine - Diarylthioether - Aryl thioether - Tertiary aliphatic/aromatic amine - Para-thiazine - Aryl chloride - Aryl halide - Benzenoid - Tertiary aliphatic amine - Tertiary amine - Azacycle - Thioether - Organic nitrogen compound - Organonitrogen compound - Organochloride - Organohalogen compound - Hydrocarbon derivative - Organopnictogen compound - Amine - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as phenothiazines. These are polycyclic aromatic compounds containing a phenothiazine moiety, which is a linear tricyclic system that consists of a two benzene rings joined by a para-thiazine ring.
External Descriptors phenothiazines - tertiary amine - organochlorine compound

Associated Targets(Human)

CYP1A2 Tchem Cytochrome P450 1A2 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CYP2D6 Tclin Cytochrome P450 2D6 (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
DRD1 Tclin D(1A) dopamine receptor (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
DRD2 Tclin D(2) dopamine receptor (14 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
DRD4 Tchem D(4) dopamine receptor (4 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CYP3A4 Tclin Cytochrome P450 3A4 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
ABCB1 Tchem Multidrug resistance protein 1 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
HRH1 Tclin Histamine H1 receptor (5 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
SLC6A2 Tclin Sodium-dependent noradrenaline transporter (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
SLC6A4 Tclin Sodium-dependent serotonin transporter (4 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
SIGMAR1 Tclin Sigma non-opioid intracellular receptor 1 (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
DRD3 Tclin D(3) dopamine receptor (12 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
DRD5 Tchem D(1B) dopamine receptor (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CHRM5 Tclin Muscarinic acetylcholine receptor M5 (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
ADRA2B Tclin Alpha-2B adrenergic receptor (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
ADRA2C Tclin Alpha-2C adrenergic receptor (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
HTR2A Tclin 5-hydroxytryptamine receptor 2A (8 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
HTR7 Tclin 5-hydroxytryptamine receptor 7 (7 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
ADRA1D Tclin Alpha-1D adrenergic receptor (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
AOX1 Tchem Aldehyde oxidase (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
HTR2C Tclin 5-hydroxytryptamine receptor 2C (6 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
HTR1A Tclin 5-hydroxytryptamine receptor 1A (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
HTR6 Tchem 5-hydroxytryptamine receptor 6 (7 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
HTR2B Tclin 5-hydroxytryptamine receptor 2B (3 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
KCNK2 Tclin Potassium channel subfamily K member 2 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 (10 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
VDR Tclin Vitamin D receptor (26531 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CRHR1 Tclin Corticotropin releasing factor receptor 1 (2996 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
GCGR Tclin Glucagon receptor (2563 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Associated Targets(non-human)

TPR Trypanothione reductase (189 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Htr7 Serotonin 7 (5-HT7) receptor (19 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Ltc4s Leukotriene C4 synthase (1 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Ntsr1 Neurotensin receptor 1 (48 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Bdkrb1 Bradykinin B1 receptor (77 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Abcb1b P-glycoprotein 1 (174 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Nr1i3 Constitutive androstane receptor (427 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mycobacterium avium (4587 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Pneumocystis carinii (749 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Saccharomyces cerevisiae (19171 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mycolicibacterium smegmatis (8003 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania infantum (5912 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Entamoeba histolytica (2676 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Cryptosporidium parvum (1150 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania amazonensis (3813 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania donovani (89745 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania major (2877 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Leishmania mexicana (936 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Canis familiaris (36305 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Felis catus (3858 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Oryctolagus cuniculus (11301 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Gerbillinae (442 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mus musculus (284745 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Sindbis virus (1599 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Plasmodium yoelii nigeriensis (1119 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Trypanosoma brucei rhodesiense (7991 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Vero (26788 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ScN2a (522 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
lef Anthrax lethal factor (7585 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ATP2A1 Sarcoplasmic/endoplasmic reticulum calcium ATP-ase (121 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Squirrel monkey (98 Activities)
Activity Type Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Names and Identifiers

IUPAC Name 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine
INCHI InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3
InChIKey ZPEIMTDSQAKGNT-UHFFFAOYSA-N
Smiles CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
Isomeric SMILES CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
Molecular Weight 318.9
Reaxy-Rn 289793
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=289793&ln=

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

Molecular Weight 318.900 g/mol
XLogP3 5.200
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 4
Exact Mass 318.096 Da
Monoisotopic Mass 318.096 Da
Topological Polar Surface Area 31.800 Ų
Heavy Atom Count 21
Formal Charge 0
Complexity 339.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Citations of This Product

1. Xucan Yang, Lulu Cheng, Yile Zhao, Haoran Ma, Haitao Song, Xuanmin Yang, Kang-Nan Wang, Yanrong Zhang.  (2024)  Aggregation-induced emission-active iridium (III)-based mitochondria-targeting nanoparticle for two-photon imaging-guided photodynamic therapy.  JOURNAL OF COLLOID AND INTERFACE SCIENCE,  659  (320). 
2. Xin Yang, Wanqiong Li, Shuzhen Li, Shaomeng Chen, Zheng Hu, Zhuoying He, Xueqin Zhu, Xiaoshuang Niu, Xiuman Zhou, Huihao Li, Youmei Xiao, Juan Liu, Xinghua Sui, Guanyu Chen, Yanfeng Gao.  (2024)  Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy.  JOURNAL OF CONTROLLED RELEASE,  365  (654). 
3. Shui Ling Yi, Zi Ling Li, Yan Chun Gong, Xiang Yuan Xiong.  (2023)  Inhibiting Multidrug Resistance with Transferrin-Targeted Polymersomes through Optimization of Ligand Density.  LANGMUIR,  39  (45): (15920–15931). 
4. Gongxi Qiao, Xuming Pan, Mengyun He, Ruixi Peng, Xiangrong Huang, Cunpeng Nie, Jianhui Jiang, Xia Chu.  (2023)  An ultrathin Zn-based layered double hydroxides augment degradation of mutant p53 to improve tumor therapy.  CHEMICAL ENGINEERING JOURNAL,  475  (146449). 
5. Jianbo Li, Yaru Xu, Jieke Zhang, Qinglian Li, Chenxu Wang, Zhe Wu, Weijing Yang, Meng Xu, Zhenzhong Zhang, Lei Wang, Jinjie Zhang.  (2023)  Bioinspired fine-tuning of the mechanical rigidity of SNEDDS for the efficient crossing of multiple gastrointestinal barriers.  JOURNAL OF CONTROLLED RELEASE,  362  (170). 
6. Mingqiao Li, Hedan Xu, Nan Zhao, Liangjun Zhang, Haihan Xia, Xiaoxun Zhang, Qiao Li, Min Liao, Qiong Pan, Zeng Yi, Jin Chai.  (2023)  Hepatocyte-targeted hyaluronic acid-polyethyleneimine conjugates for acute liver injury therapy by ROS elimination and inflammation modulation.  MATERIALS & DESIGN,  233  (112212). 
7. Zhanlin Zhang, Hui Yan, Wenxiong Cao, Shuang Xie, Pan Ran, Kun Wei, Xiaohong Li.  (2023)  Ultrasound-Chargeable Persistent Luminescence Nanoparticles to Generate Self-Propelled Motion and Photothermal/NO Therapy for Synergistic Tumor Treatment.  ACS Nano,     
8. Peifu Xiao, Xiaoguang Tao, Hanxun Wang, Hongbing Liu, Yupeng Feng, Yueqi Zhu, Zhengzhen Jiang, Tian Yin, Yu Zhang, Haibing He, Jingxin Gou, Xing Tang.  (2023)  Enzyme/pH dual stimuli-responsive nanoplatform co-deliver disulfiram and doxorubicin for effective treatment of breast cancer lung metastasis.  Expert Opinion on Drug Delivery,  20  (7): (1015-1031). 
9. Huanhuan Yang, Cong Liu, Chuanhong Zhu, Yan Zheng, Juan Li, Qianyun Zhu, Hao Wang, Xiangming Fang, Quan Liu, Man Liang, Zilong Liu.  (2023)  Determination of ten antipsychotics in blood, hair and nails: Validation of a LC–MS/MS method and forensic application of keratinized matrix analysis.  JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,  234  (115557). 
10. Wenjing Huang, Li Wang, Hao Zhang, Zhihao Han, Yueqing Gu.  (2023)  Near-infrared targeted EGFR fluorescent probe for tumor imaging and diagnosis.  SENSORS AND ACTUATORS B-CHEMICAL,  393  (134102). 
11. Ping Guan, Zhaoxu Meng, Xinran Liu, Jiaxiang Mu, Zichun Gao, Xinrong Yu, He Lian.  (2023)  A biomimetic mineralization nanosystem based on glycolysis-oxidative stress-autophagy regulation for the suppression of malignant tumor and lung metastasis.  CHEMICAL ENGINEERING JOURNAL,  468  (143730). 
12. Shengnan Huang, Chengzhi Song, Jinxin Miao, Xiali Zhu, Yongyan Jia, Yafei Liu, Dongjun Fu, Benyi Li, Mingsan Miao, Shaofeng Duan, Zhenzhong Zhang, Yurong Hu.  (2023)  Red blood cell membrane-coated functionalized Au nanocage as a biomimetic platform for improved MicroRNA delivery in hepatocellular carcinoma.  INTERNATIONAL JOURNAL OF PHARMACEUTICS,  642  (123044). 
13. Xuan Nie, Wei You, Ze Zhang, Fan Gao, Xiao-Hong Zhou, Hai-Li Wang, Long-Hai Wang, Guang Chen, Chang-Hui Wang, Chun-Yan Hong, Qi Shao, Fei Wang, Lei Xia, Yang Li, Ye-Zi You.  (2023)  DPA-Zinc around Polyplexes Acts Like PEG to Reduce Protein Binding While Targeting Cancer Cells.  Advanced Healthcare Materials,  12  (21): (2203252). 
14. Xin Chang, Chang Liu, Yu-Mo Han, Qiu-Ling Li, Bin Guo, Hu-Lin Jiang.  (2023)  Efficient transfected liposomes co-loaded with pNrf2 and pirfenidone improves safe delivery for enhanced pulmonary fibrosis reversion.  Molecular Therapy-Nucleic Acids,  32  (415-431). 
15. Yajing Wang, Ziwei Ding, Shiqun Lv, Jie Liu, Jie Pan, Yingcong Yu, Jun Gao, Xianfeng Huang.  (2023)  Development of tLyP-1 functionalized nanoliposomes with tunable internal water phase for glioma targeting.  JOURNAL OF LIPOSOME RESEARCH,     
16. Cen Chen, Yuhang Zhang, Yulong Tang, Guangrong Huang, Han Jiang.  (2023)  Preparation of magnetic molecularly imprinted polymers for selective extraction of xylazine in milk.  INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY,  58  (5): (2599-2608). 
17. Junwu Wei, Yuan Liu, Yingxin Li, Zhanlin Zhang, Jie Meng, Shuang Xie, Xiaohong Li.  (2023)  Photothermal Propelling and Pyroelectric Potential-Promoted Cell Internalization of Janus Nanoparticles and Pyroelectrodynamic Tumor Therapy.  Advanced Healthcare Materials,  12  (18): (2300338). 
18. Yanzhi Xing, Yulong Xu, Yanna Lin, E Shuang, Han Leng, Jianhua Wang, Xuwei Chen.  (2023)  Rational synthesis of carbon dots with phosphate ester group for direct mapping of endogenous alkaline phosphatase and polarity monitoring in living cells.  JOURNAL OF COLLOID AND INTERFACE SCIENCE,  640  (626). 
19. Han Haobo, Xing Jiakai, Chen Wenqi, Jia Jiaxin, Li Quanshun.  (2023)  Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats.  Nature Communications,  14  (1): (1-20). 
20. Wen-Juan Shen, Duo-Mei Tian, Le Fu, Biao Jin, Yu Liu, Yun-Sheng Xu, Yong-Bin Ye, Xiao-Bo Wang, Xiao-Jun Xu, Chun Tang, Fang-Ping Li, Chun-Fei Wang, Gang Wu, Le-Ping Yan.  (2023)  Elastin-Derived VGVAPG Fragment Decorated Cell-Penetrating Peptide with Improved Gene Delivery Efficacy.  Pharmaceutics,  15  (2): (670). 
21. Nini Xin, Dong Gao, Borui Su, Ting Zhou, Yuda Zhu, Chengheng Wu, Dan Wei, Jing Sun, Hongsong Fan.  (2023)  Orange-Emissive Carbon Dots with High Photostability for Mitochondrial Dynamics Tracking in Living Cells.  ACS Sensors,  (3): (1161–1172). 
22. Zhanlin Zhang, Tian Xia, Pan Ran, Junwu Wei, Jie Meng, Guiyuan Zhang, Xiaohong Li.  (2023)  Persistent luminescence-activated Janus nanomotors with integration of photodynamic and photothermal cancer therapies.  CHEMICAL ENGINEERING JOURNAL,  457  (141226). 
23. Li Fangyuan, Sun Heng, Ren Jiafeng, Zhang Bo, Hu Xi, Fang Chunyan, Lee Jiyoung, Gu Hongzhou, Ling Daishun.  (2022)  A nuclease-mimetic platinum nanozyme induces concurrent DNA platination and oxidative cleavage to overcome cancer drug resistance.  Nature Communications,  13  (1): (1-16). 
24. Qianqian Han, Tongtong Zhang, Meifang Wang, Fei Yan, Jiyang Liu.  (2022)  Disposable Electrochemical Sensors for Highly Sensitive Detection of Chlorpromazine in Human Whole Blood Based on the Silica Nanochannel Array Modified Screen-Printed Carbon Electrode.  MOLECULES,  27  (23): (8200). 
25. Jie Yang, Xiuhua Pan, Jun Zhang, Siyu Ma, Jianeng Zhou, Zengguang Jia, Yawen Wei, Zengyi Liu, Ning Yang, Qi Shen.  (2022)  Reprogramming dysfunctional dendritic cells by a versatile metabolism nano-intervenor for enhancing cancer combinatorial immunotherapy.  Nano Today,  46  (101618). 
26. Yongtao You, Silan Bai, Yamin Ma, Cheng Liu, Lishi Wang.  (2022)  A Nanopipette Supported Oil/Water Interface Sensor for the Kinetics Analysis and Determination of Phenothiazine Derivatives.  ELECTROCHIMICA ACTA,  423  (140568). 
27. Hou Zhenyu, Zhou Mei, Ma Yuanyuan, Xu Xiaoxuan, Zhang Zhiqi, Lai Shiwei, Fan Wenpei, Xie Jinbing, Ju Shenghong.  (2022)  Size-changeable nanoprobes for the combined radiotherapy and photodynamic therapy of tumor.  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING,  49  (8): (2655-2667). 
28. Peng Hua, Donglin Yang, Ruie Chen, Peiqi Qiu, Meiwan Chen.  (2022)  ROS responsive polyethylenimine-based fluorinated polymers for enhanced transfection efficiency and lower cytotoxicity.  Bosnian Journal of Basic Medical Sciences,  22  (4): ( 593–607). 
29. Ruoning Wang, Qifan Liang, Xinru Zhang, Zhenning Di, Xiaohong Wang, Liuqing Di.  (2022)  Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment.  COLLOIDS AND SURFACES B-BIOINTERFACES,  215  (112505). 
30. Lijuan Yang, Shaochi Liu, Tian Quan, Yongqing Tao, Meng Tian, Luchun Wang, Junji Wang, Dandan Wang, Die Gao.  (2022)  Sulfuric-acid-mediated synthesis strategy for multi-colour aggregation-induced emission fluorescent carbon dots: Application in anti-counterfeiting, information encryption, and rapid cytoplasmic imaging.  JOURNAL OF COLLOID AND INTERFACE SCIENCE,  612  (650). 
31. Zhuxian Wang, Yaqi Xue, Quanfu Zeng, Zhaoming Zhu, Yuan Wang, Yufan Wu, Chunyan Shen, Hongxia Zhu, Cuiping Jiang, Li Liu, Qiang Liu.  (2022)  Glycyrrhiza acid-Licochalcone A complexes for enhanced bioavailability and anti-melanogenic effect of Licochalcone A: cellular uptake and in vitro experiments.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  68  (103037). 
32. Li Wu, Yan Shi, Zihui Ni, Tao Yu, Zhipeng Chen.  (2022)  Preparation of a Self-Assembled Rhein–Doxorubicin Nanogel Targeting Mitochondria and Investigation on Its Antihepatoma Activity.  MOLECULAR PHARMACEUTICS,  19  (1): (35–50). 
33. Suleixin Yang, Ka Hong Wong, Peng Hua, Chengwei He, Hua Yu, Dan Shao, Zhi Shi, Meiwan Chen.  (2022)  ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.  Acta Biomaterialia,  140  (492). 
34. Dan Wang, Wenkai Feng, Xiaowei Wang, Dongfang Lin, Xuelei Wang, Xiaoru Guo, Qingfang Miao, Jie Ma, Guimin Xia.  (2021)  Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle.  EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,  167  (106000). 
35. Yu Liu, Huan-Huan Wan, Duo-Mei Tian, Xiao-Jun Xu, Chang-Long Bi, Xiao-Yong Zhan, Bi-Hui Huang, Yun-Sheng Xu, Le-Ping Yan.  (2021)  Development and Characterization of High Efficacy Cell-Penetrating Peptide via Modulation of the Histidine and Arginine Ratio for Gene Therapy.  Materials,  14  (16): (4674). 
36. Yu Zhang, Junxi Liu, Pengfei Dou, Zhijing Wu, Ziming Zheng, Xianglin Pan, Tao Zhou, Kaiping Wang.  (2021)  Oral absorption characteristics and mechanisms of a pectin-type polysaccharide from Smilax china L. across the intestinal epithelium.  CARBOHYDRATE POLYMERS,  270  (118383). 
37. Mengqin Gu, Li Jiang, Liying Hao, Junzhuo Lu, Zhenqi Liu, Zixue Lei, Yijun Li, Chengge Hua, Wei Li, Xiyu Li.  (2021)  A novel theranostic nanoplatform for imaging-guided chemo-photothermal therapy in oral squamous cell carcinoma.  Journal of Materials Chemistry B,  (30): (6006-6016). 
38. Ziming Zheng, Xianglin Pan, Haoyu Wang, Zhijing Wu, Mitchell A. Sullivan, Yuxuan Liu, Junxi Liu, Kaiping Wang, Yu Zhang.  (2021)  Mechanism of Lentinan Intestinal Absorption: Clathrin-Mediated Endocytosis and Macropinocytosis.  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,  69  (26): (7344–7352). 
39. Lei Luo, Min Wang, Yuan Zhou, Dongliu Xiang, Qing Wang, Jin Huang, Jianbo Liu, Xiaohai Yang, Kemin Wang.  (2021)  Ratiometric Fluorescent DNA Nanostructure for Mitochondrial ATP Imaging in Living Cells Based on Hybridization Chain Reaction.  ANALYTICAL CHEMISTRY,  93  (17): (6715–6722). 
40. Qiu-Ping Feng, Yu-Ting Zhu, Yi-Zhen Yuan, Wen-Jie Li, Hao-Han Yu, Meng-Yuan Hu, Su-Yun Xiang, Shu-Qin Yu.  (2021)  Oral administration co-delivery nanoparticles of docetaxel and bevacizumab for improving intestinal absorption and enhancing anticancer activity.  Materials Science & Engineering C-Materials for Biological Applications,  124  (112039). 
41. Meng-Xian Liu, Na Ding, Shuai Chen, Yong-Liang Yu, Jian-Hua Wang.  (2021)  One-Step Synthesis of Carbon Nanoparticles Capable of Long-Term Tracking Lipid Droplet for Real-Time Monitoring of Lipid Catabolism and Pharmacodynamic Evaluation of Lipid-Lowering Drugs.  ANALYTICAL CHEMISTRY,  93  (12): (5284–5290). 
42. Yuping Wei, Caiying Zhang, Man Zhang, Qionghong Niu, Fengli Hui, Zi Liu, Xia Xu.  (2021)  Insight of Synergistic Effect between CPP and Cargo on the Facilitation Mechanisms of R7-PTX Translocation: Experiments and Molecular Simulations.  EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,  161  (105790). 
43. Weng Qinjie, Sun Heng, Fang Chunyan, Xia Fan, Liao Hongwei, Lee Jiyoung, Wang Jincheng, Xie An, Ren Jiafeng, Guo Xia, Li Fangyuan, Yang Bo, Ling Daishun.  (2021)  Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics.  Nature Communications,  12  (1): (1-14). 
44. Dengshuai Wei, Yingjie Yu, Xingcai Zhang, Yongheng Wang, Hao Chen, Yao Zhao, Fuyi Wang, Guanghua Rong, Wenwen Wang, Xiang Kang, Jing Cai, Zehua Wang, Ji-Ye Yin, Muhammad Hanif, Yongbing Sun, Gaofeng Zha, Linxian Li, Guohui Nie, Haihua Xiao.  (2020)  Breaking the Intracellular Redox Balance with Diselenium Nanoparticles for Maximizing Chemotherapy Efficacy on Patient-Derived Xenograft Models.  ACS Nano,  14  (12): (16984–16996). 
45. Rong Rao, Xuhan Liu, Yinghuan Li, Xi Tan, Hong Zhou, Xicheng Bai, Xiangliang Yang, Wei Liu.  (2021)  Bioinspired zwitterionic polyphosphoester modified porous silicon nanoparticles for efficient oral insulin delivery.  Biomaterials Science,  (3): (685-699). 
46. Hu Gaowei, Miao Yingjie, Luo Xi, Chu Wenhui, Fu Yongqian.  (2020)  Identification of a novel cell-penetrating peptide derived from the capsid protein of chicken anemia virus and its application in gene delivery.  APPLIED MICROBIOLOGY AND BIOTECHNOLOGY,  104  (24): (10503-10513). 
47. Zhanlin Zhang, Hui Yan, Shang Li, Yuan Liu, Pan Ran, Weijia Chen, Xiaohong Li.  (2021)  Janus rod-like micromotors to promote the tumor accumulation and cell internalization of therapeutic agents.  CHEMICAL ENGINEERING JOURNAL,  404  (127073). 
48. Xinyi Tan, Na Yin, Zixu Liu, Rong Sun, Jingxin Gou, Tian Yin, Yu Zhang, Haibing He, Xing Tang.  (2020)  Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.  MOLECULAR PHARMACEUTICS,  17  (9): (3177–3191). 
49. Le Feng, Xiao Xiao, Jing Liu, Junyan Wang, Nan Zhang, Tao Bing, Xiangjun Liu, Ziping Zhang, Dihua Shangguan.  (2020)  Immunomodulatory Effects of Lycium barbarum Polysaccharide Extract and Its Uptake Behaviors at the Cellular Level.  MOLECULES,  25  (6): (1351). 
50. E. Shuang, Quan-Xing Mao, Jian-Hua Wang, Xu-Wei Chen.  (2020)  Carbon dots with tunable dual emissions: from the mechanism to the specific imaging of endoplasmic reticulum polarity.  Nanoscale,  12  (12): (6852-6860). 
51. Jian Wang, Yangyang Li, Shouyu Wang, Fei Liu.  (2020)  Dynamics of transmissible gastroenteritis virus internalization unraveled by single-virus tracking in live cells.  FASEB JOURNAL,  34  (3): (4653-4669). 
52. Chen Xiaolong, Hu Cuihua, Zhang Yanan, Hao Wenjing, He Xu, Li Qing, Huang Yuxi, Huang Yibing, Chen Yuxin.  (2020)  Anticancer Activity and Mechanism of Action of kla-TAT Peptide.  International Journal of Peptide Research and Therapeutics,  26  (4): (2285-2296). 
53. Siyu Guan, Qianqian Zhang, Jianwei Bao, Tijie Duan, Rongfeng Hu, Tori Czech, Jihui Tang.  (2020)  Phosphatidylserine targeting peptide-functionalized pH sensitive mixed micelles for enhanced anti-tumor drug delivery.  EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS,  147  (87). 
54. Yajun Liu, Rui Dai, Qiuyu Wei, Wenzhe Li, Guang Zhu, Hao Chi, Zhaoming Guo, Li Wang, Changhao Cui, Jianqiang Xu, Kun Ma.  (2019)  Dual-Functionalized Janus Mesoporous Silica Nanoparticles with Active Targeting and Charge Reversal for Synergistic Tumor-Targeting Therapy.  ACS Applied Materials & Interfaces,  11  (47): (44582–44592). 
55. Tingting Luo, Jingtian Han, Feng Zhao, Xiaohong Pan, Baocheng Tian, Xiujuan Ding, Jing Zhang.  (2019)  Redox-sensitive micelles based on retinoic acid modified chitosan conjugate for intracellular drug delivery and smart drug release in cancer therapy.  CARBOHYDRATE POLYMERS,  215  (8). 
56. Lipeng Qiu, Xiaotian Shan, Miaomiao Long, Kamel S. Ahmed, Li Zhao, Jing Mao, Huijie Zhang, Changling Sun, Chongzhao You, Guozhong Lv, Jinghua Chen.  (2019)  Elucidation of cellular uptake and intracellular trafficking of heparosan polysaccharide-based micelles in various cancer cells.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,  130  (755). 
57. Chunlai Feng, Haisheng Zhang, Jiaming Chen, Siqi Wang, Yuanrong Xin, Yang Qu, Qi Zhang, Wei Ji, Fumiyoshi Yamashita, Mengjie Rui, Ximing Xu.  (2019)  Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.  INTERNATIONAL JOURNAL OF PHARMACEUTICS,  560  (191). 
58. Shuang E, Quan-Xing Mao, Xiao-Li Yuan, Xiao-Lei Kong, Xu-Wei Chen, Jian-Hua Wang.  (2018)  Targeted imaging of the lysosome and endoplasmic reticulum and their pH monitoring with surface regulated carbon dots.  Nanoscale,  10  (26): (12788-12796). 
59. Hu Gaowei, Zheng Wenlv, Li Ao, Mu Yaru, Shi Mingyu, Li Tuofan, Zou Haitao, Shao Hongxia, Qin Aijian, Ye Jianqiang.  (2018)  A novel CAV derived cell-penetrating peptide efficiently delivers exogenous molecules through caveolae-mediated endocytosis.  VETERINARY RESEARCH,  49  (1): (1-9). 
60. Zhou Yang, Fan Wu, Hongjie Yang, Ping Zhou.  (2017)  Endocytosis mechanism of a novel proteoglycan, extracted from Ganoderma lucidum, in HepG2 cells.  RSC Advances,  (66): (41779-41786). 
61. Yue Yang, Xiaoyu Lu, Qi Liu, Yu Dai, Xiaojie Zhu, Yanli Wen, Jiaqiu Xu, Yang Lu, Di Zhao, Xijing Chen, Ning Li.  (2017)  Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.  EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,  105  (219). 
62. Wenqi Chen, Yong Liu, Xiao Liang, Yu Huang, Quanshun Li.  (2017)  Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery.  Acta Biomaterialia,  57  (238). 
63. Xian Sun, Yingping Luo, Liwei Huang, Bo-Yang Yu, Jiangwei Tian.  (2017)  A peptide-decorated and curcumin-loaded mesoporous silica nanomedicine for effectively overcoming multidrug resistance in cancer cells.  RSC Advances,  (27): (16401-16409). 
64. Liu Di, Guo Hua, Zheng Wenyun, Zhang Na, Wang Tianwen, Wang Ping, Ma Xingyuan.  (2016)  Discovery of the cell-penetrating function of A2 domain derived from LTA subunit of Escherichia coli heat-labile enterotoxin.  APPLIED MICROBIOLOGY AND BIOTECHNOLOGY,  100  (11): (5079-5088). 
65. Zhen Xing, Sai Gao, Yan Duan, Haobo Han, Li Li, Yan Yang, Quanshun Li.  (2015)  Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.  International Journal of Nanomedicine,     
66. Kambere Amerigos Daddy J C,Minglei Chen,Faisal Raza,Yanyu Xiao,Zhigui Su,Qineng Ping.  (2020-02-28)  Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia..  Pharmaceutics,  12  ((2)):  
67. MengYing Lei, Qing Chen, Yang Wang, Gang Wang.  (2024)  A facile carrier-free co-assembly nanoplatform for effective enhanced oral chemotherapy.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  95  (105651). 
68. Huang Lanli, Yao Yi, Ruan Zhuren, Zhang Shengqing, Feng Xianjing, Lu Chun, Zhao Jinmin, Yin Feiying, Cao Cunwei, Zheng Li.  (2024)  Baicalin nanodelivery system based on functionalized metal-organic framework for targeted therapy of osteoarthritis by modulating macrophage polarization.  JOURNAL OF NANOBIOTECHNOLOGY,  22  (1): (1-19). 
69. Xiuhua Pan, Jie Yang, Ruixin Kang, Jun Zhang, Zongwei Hu, Ning Yang, Zengyi Liu, Zengguang Jia, Xiawei Zhou, Qi Shen.  (2024)  Biomimetic bacteria-derived nanoclusters enhance ferroptosis cancer immunotherapy through synergistic CRISPR-photothermo modulation.  Nano Today,  55  (102213). 
70. Shuangqian Yan, Panpan Xue, Ying Sun, Tingjie Bai, Sijie Shao, Xuemei Zeng.  (2024)  Cupric Doping Hollow Prussian Blue Nanoplatform for Enhanced Cholesterol Depletion: a Promising Strategy for Breast Cancer Therapy and Metastasis Inhibition.  Advanced Science,    (2409967). 
71. Dan Li, Gaoyang Yi, Guifang Cao, Adam C. Midgley, Yongli Yang, Dan Yang, Wenguang Liu, Yujuan He, Xiaolin Yao, Guoliang Li.  (2025)  Dual-Carriers of Tartary Buckwheat-Derived Exosome-Like Nanovesicles Synergistically Regulate Glucose Metabolism in the Intestine-Liver Axis.  Small,    (2410124). 
72. Zhoujiang Chen, Lianlin Long, Ji Wang, Mingli Jiang, Wei Li, Wenguo Cui, Liang Zou.  (2024)  Enhanced Tumor Site Accumulation and Therapeutic Efficacy of Extracellular Matrix-Drug Conjugates Targeting Tumor Cells.  Small,    (2402040). 
73. Yanzhi Xing, Jiaxin Li, Han Leng, Yanfeng Zhang, Shuang E, Jianhua Wang, Xuwei Chen.  (2024)  From cell membrane to endoplasmic reticulum: Tunable lipid membrane imaging by regulating the lipophilicity and internalization of carbon dots.  CHEMICAL ENGINEERING JOURNAL,  492  (152068). 
74. Jie Meng, Wei Wei, Shuang Xie, Junwu Wei, Zhanlin Zhang, Pan Ran, Xiaohong Li.  (2024)  Hollow and heterojunction-structured Janus nanomotors for pyroelectrodynamic and nanozyme-catalyzed tumor therapy.  CHEMICAL ENGINEERING JOURNAL,  501  (157763). 
75. Wubuli Abudukahaer, Chai Junwei, Liu Haoqiang, Nijat Dilaram, Li Jianmin, Xia Guoyu, Cao Qi, Zhang Saidan, Huang Weidong, Aipire Adila, Li Jinyao.  (2024)  In vivo pharmacokinetics of Glycyrrhiza uralensis polysaccharides.  Frontiers in Pharmacology,  15   
76. Junxi Liu, Xiaoke Zhang, Yan Liu, Zhijing Wu, Zheng Cui, Xianglin Pan, Yuheng Zheng, Jinglin Wang, Kaiping Wang, Yu Zhang.  (2024)  Intestinal lymphatic transport of Smilax china L. pectic polysaccharide via Peyer's patches and its uptake and transport mechanisms in mononuclear phagocytes.  CARBOHYDRATE POLYMERS,  339  (122256). 
77. Jinzhao Liu, Meicen Wu, Qingyang Lyu, Chang Yang, Ni Fan, Kang Chen, Weiping Wang.  (2025)  IR783-Stabilized Nanodrugs Enhance Anticancer Immune Response by Synergizing Oxidation Therapy and Epigenetic Modulation.  Advanced Science,    (2415684). 
78. Li Bo, Zhao Qianhui, Yang Hanyu, Wang Xueyuying, Zhang Zhijun, Gong Yanling, Wan Xu.  (2024)  Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells.  AAPS PHARMSCITECH,  25  (8): (1-12). 
79. Yadan Zhang, Xiaoyu Zhang, Tianhan Kai, Lin Zhang, Anping Li.  (2024)  Lycium ruthenicum Murray derived exosome-like nanovesicles inhibit Aβ-induced apoptosis in PC12 cells via MAPK and PI3K/AKT signaling pathways.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,  277  (134309). 
80. Weiyi Lu, Bin Yang, Zihua Guo, Zhen Tian, Wenhui He, Tiancheng Yang.  (2024)  Machine learning-based fluorescence sensor array: Accurate discrimination, quantitative assay of phenothiazine drugs via versatile DNA probes.  SENSORS AND ACTUATORS B-CHEMICAL,  405  (135330). 
81. Pengfei Yuan, Xiaodie Yan, Xiaoqing Zong, Xiaodi Li, Caiqi Yang, Xinjie Chen, Yuchao Li, Yaoqi Wen, Tianci Zhu, Wei Xue, Jian Dai.  (2024)  Modulating Elasticity of Liposome for Enhanced Cancer Immunotherapy.  ACS Nano,  18  (34): (23797-23811). 
82. Rui Li, Wenhui Ruan, Rui Hao, Jue Chen, Chu Xu, Liyan Lu, Yingli Wang.  (2025)  O-carboxymethyl chitosan-grafted-cholesterol succinic acid monoester nanomicelles improve oral absorption of cannabidiol: Preparation, intestinal absorption in vitro, and pharmacokinetics in vivo.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,    (106763). 
83. Tang Bo, Wang Qiuxiang, Zhang Guowei, Zhang Aiwen, Zhu Lu, Zhao Rongrong, Gu Hongwei, Meng Jie, Zhang Junfang, Fang Guihua.  (2024)  OCTN2- and ATB0,+-targeted nanoemulsions for improving ocular drug delivery.  JOURNAL OF NANOBIOTECHNOLOGY,  22  (1): (1-19). 
84. Dan Yang, Yuqi Feng, Ying Yuan, Linxuan Zhang, Yao Zhou, Adam C. Midgley, Yanrong Wang, Ning Liu, Guoliang Li, Xiaolin Yao, Dechun Liu.  (2024)  Protein Coronas Derived from Mucus Act as Both Spear and Shield to Regulate Transferrin Functionalized Nanoparticle Transcellular Transport in Enterocytes.  ACS Nano,     
85. Zhaoxin Xia, Yulong Liao, Ge Gao, Shiyong Zhang.  (2024)  Rifampicin-Loaded Polyelectrolyte Complex Eliminates Intracellular Bacteria through Thiol-Mediated Cellular Uptake and Oxidative Stress Enhancement.  ACS Applied Bio Materials,  (4): (2544-2553). 
86. Xiuhua Pan, Feiyang Liu, Ruixin Kang, Zongwei Hu, Yueru Pang, Ziqi Shen, Xiawei Zhou, Jun Zhang, Qi Shen.  (2024)  Self-Adjuvanting Bacteria Hydrogel for SHP1 Checkpoint Inhibition in Tumor-Draining Lymph Nodes to Enhance Cancer Immunotherapy.  ADVANCED FUNCTIONAL MATERIALS,    (2409736). 
87. Caifeng Deng, Yongbing Xiao, Xuan Zhao, Hui Li, Yuxiao Chen, Kelong Ai, Ting Jiang, Jie Wei, Xiaoyuan Chen, Guanghua Lei, Chao Zeng.  (2025)  Sequential Targeting Chondroitin Sulfate-Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages.  Advanced Science,    (2411911). 
88. Yongzhi Chen, Qiuxia Tan, Yuanyu Tang, E. Pang, Rui Peng, Minhuan Lan, Dousheng Bai.  (2024)  Sorafenib and tetrakis (4-carboxyphenyl) porphyrin assembled nanoparticles for synergistic targeted chemotherapy and sonodynamic therapy of hepatocellular carcinoma.  Biomaterials Science,     
89. Yiming Wang, Chen Wang, Yuan Lu.  (2024)  Spleen Targeting Nucleic Acid Delivery Vector Based on Metal–Organic Frameworks.  ACS Applied Materials & Interfaces,  16  (42): (56826-56836). 
90. Liangxing Tu, Ping Han, Yongbing Sun, Yi Jin, Kaili Hu, Meng Cheng, Yisen Shao, Jianfang Feng, Fangying Yuan.  (2024)  Study on the preparation of stabilizer-free silymarin nanocrystals and its oral absorption mechanisms.  International Journal of Pharmaceutics-X,    (100292). 
91. Zhan Ying, Mao Yichun, Sun Pei, Liu Chenbin, Gou Hongquan, Qi Haipeng, Chen Guifang, Hu Song, Tian Bo.  (2024)  Tumor-associated antigen-specific cell imaging based on upconversion luminescence and nucleic acid rolling circle amplification.  MICROCHIMICA ACTA,  191  (5): (1-11). 

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.